标题
Pharmacological small molecules for the treatment of lysosomal storage disorders
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 19, Issue 11, Pages 1367-1379
出版商
Informa Healthcare
发表日期
2010-10-13
DOI
10.1517/13543784.2010.524205
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Palmitoyl:protein thioesterase (PPT1) inhibitors can act as pharmacological chaperones in infantile Batten disease
- (2010) Glyn Dawson et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- 2,5-Dideoxy-2,5-imino-d-altritol as a new class of pharmacological chaperone for Fabry disease
- (2010) Atsushi Kato et al. BIOORGANIC & MEDICINAL CHEMISTRY
- A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1
- (2010) E. Lukina et al. BLOOD
- The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of β-glucosidase
- (2010) Richie Khanna et al. FEBS Journal
- Improved management of lysosomal glucosylceramide levels in a mouse model of type 1 Gaucher disease using enzyme and substrate reduction therapy
- (2010) John Marshall et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Molecular Characterization of Mutations That Cause Globoid Cell Leukodystrophy and Pharmacological Rescue Using Small Molecule Chemical Chaperones
- (2010) W. C. Lee et al. JOURNAL OF NEUROSCIENCE
- Hsp70 stabilizes lysosomes and reverts Niemann–Pick disease-associated lysosomal pathology
- (2010) Thomas Kirkegaard et al. NATURE
- Endoplasmic reticulum Ca2+ increases enhance mutant glucocerebrosidase proteostasis
- (2010) Derrick Sek Tong Ong et al. Nature Chemical Biology
- Niemann-Pick disease type C
- (2010) Marie T Vanier Orphanet Journal of Rare Diseases
- Glycosphingolipids-Nature, Function, and Pharmacological Modulation
- (2009) Tom Wennekes et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Promising results of the chaperone effect caused by iminosugars and aminocyclitol derivatives on mutant glucocerebrosidases causing Gaucher disease
- (2009) Gessamí Sánchez-Ollé et al. BLOOD CELLS MOLECULES AND DISEASES
- The pharmacological chaperone effect of N-octyl-β-valienamine on human mutant acid β-glucosidases
- (2009) Zhuo Luan et al. BLOOD CELLS MOLECULES AND DISEASES
- Chaperone Activity of Bicyclic Nojirimycin Analogues for Gaucher Mutations in Comparison withN-(n-nonyl)Deoxynojirimycin
- (2009) Zhuo Luan et al. CHEMBIOCHEM
- High Incidence of the Cardiac Variant of Fabry Disease Revealed by Newborn Screening in the Taiwan Chinese Population
- (2009) Hsiang-Yu Lin et al. Circulation-Cardiovascular Genetics
- Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics
- (2009) Giancarlo Parenti EMBO Molecular Medicine
- Real-world clinical experience with long-term miglustat maintenance therapy in type 1 Gaucher disease: the ZAGAL project
- (2009) P. Giraldo et al. HAEMATOLOGICA
- The pharmacological chaperone 1-deoxynojirimycin increases the activity and lysosomal trafficking of multiple mutant forms of acid alpha-glucosidase
- (2009) John J. Flanagan et al. HUMAN MUTATION
- Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onsetGLAmutation c.936+919G>A (IVS4+919G>A)
- (2009) Wuh-Liang Hwu et al. HUMAN MUTATION
- Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
- (2009) Gustavo H. B. Maegawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Long-Term Miglustat Therapy in Children With Niemann-Pick Disease Type C
- (2009) Marc C. Patterson et al. JOURNAL OF CHILD NEUROLOGY
- The pharmacological chaperone 1-deoxygalactonojirimycin increases α-galactosidase A levels in Fabry patient cell lines
- (2009) E. R. Benjamin et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Recommendations on the diagnosis and management of Niemann-Pick disease type C
- (2009) James E. Wraith et al. MOLECULAR GENETICS AND METABOLISM
- Miglustat in patients with Niemann-Pick disease Type C (NP-C): A multicenter observational retrospective cohort study
- (2009) M. Pineda et al. MOLECULAR GENETICS AND METABOLISM
- Vasculopathy in patients with Fabry disease: Current controversies and research directions
- (2009) S.M. Rombach et al. MOLECULAR GENETICS AND METABOLISM
- Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants
- (2009) Priya S. Kishnani et al. MOLECULAR GENETICS AND METABOLISM
- The Pharmacological Chaperone N-butyldeoxynojirimycin Enhances Enzyme Replacement Therapy in Pompe Disease Fibroblasts
- (2009) Caterina Porto et al. MOLECULAR THERAPY
- Miglustat (Zavesca®) in type 1 Gaucher disease: 5-year results of a post-authorisation safety surveillance programme
- (2009) Carla E. M. Hollak et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- In Vivo and Ex Vivo Evaluation of L-Type Calcium Channel Blockers on Acid β-Glucosidase in Gaucher Disease Mouse Models
- (2009) Ying Sun et al. PLoS One
- Randomized, controlled trial of miglustat in Gaucher's disease type 3
- (2008) Raphael Schiffmann et al. ANNALS OF NEUROLOGY
- Isofagomine increases lysosomal delivery of exogenous glucocerebrosidase
- (2008) Jin-Song Shen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Chemical and Biological Approaches Synergize to Ameliorate Protein-Folding Diseases
- (2008) Ting-Wei Mu et al. CELL
- Optimization and Validation of Two Miniaturized Glucocerebrosidase Enzyme Assays for High Throughput Screening
- (2008) Daniel Urban et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- Genistin-rich soy isoflavone extract in substrate reduction therapy for Sanfilippo syndrome: An open-label, pilot study in 10 pediatric patients
- (2008) Ewa Piotrowska et al. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
- Potential efficacy of enzyme replacement and substrate reduction therapy in three siblings with Gaucher disease type III
- (2008) J. Cox-Brinkman et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Ignoring the nonsense: a phase II trial in cystic fibrosis
- (2008) Stephen C Hyde et al. LANCET
- Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial
- (2008) Eitan Kerem et al. LANCET
- Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis
- (2008) Elena Elliot-Smith et al. MOLECULAR GENETICS AND METABOLISM
- Partial Restoration of Mutant Enzyme Homeostasis in Three Distinct Lysosomal Storage Disease Cell Lines by Altering Calcium Homeostasis
- (2008) Ting-Wei Mu et al. PLOS BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started